Walleye Trading LLC Clovis Oncology, Inc. Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $72,392 - $127,625	26,812 Added 918.53%	29,731 $81,000
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $91,707 - $131,010	-22,588 Reduced 88.56%	2,919 $13,000
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $30,990 - $66,620	6,443 Added 33.8%	25,507 $179,000
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $51,637 - $80,144	12,503 Added 190.57%	19,064 $92,000
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $361 - $579	-75 Reduced 1.13%	6,561 $38,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $83,130 - $455,275	-27,710 Reduced 80.68%	6,636 $69,000
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $42,479 - $165,918	-10,809 Reduced 23.94%	34,346 $135,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $566,483 - $1.14 Million	44,222 Added 4739.76%	45,155 $671,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $16,476 - $28,251	933 New	933 $23,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.